METTL3 expression levels were higher in patients in later stages of ACC and KICH; however, the expression levels of METTL3 in patients with LIHC with stage IV cancers were significantly lower than those in patients with LIHC at earlier stages. The gene discussed is METTL3; the disease is adrenal cortex carcinoma.